Paul Tudor Jones II's position in Chemed is currently worth $15.2M. That's 0.08% of their equity portfolio (310th largest holding). The first Chemed trade was made in Q2 2013. Since then Paul Tudor Jones II bought shares thirteen more times and sold shares on thirteen occasions. The stake costed the investor $14.1M, netting the investor a gain of 7.3% so far.